Ben Arye Barak bought NVCR
December 31, 2023 · Form 4 insider transaction
Ben Arye Barak bought 128 shares of NovoCure Limited at $12.69 per share, a transaction worth $1.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 60 days after the transaction.
Direction
Acquired (buy-side)
Shares
128
Price
$12.69
Total value
$1.6K
InsiderBen Arye Barak
RoleOfficer
CompanyNovoCure Limited (NVCR)
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateDecember 31, 2023
Filing dateFebruary 29, 2024
Shares owned after35,323
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2023 through December 31, 2023. This transaction is also exempt under Rule 16b-3(c).; In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2023.